# MiraLAX

NDC: 55154-5035
Generic name: Polyethylene Glycol 3350
Labeler / Manufacturer: Cardinal Health 107, LLC
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SOLUTION
Routes: ORAL
Marketing started: 20090223

FDA application: NDA022015

## Active ingredients

- POLYETHYLENE GLYCOL 3350: 17 g/17g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55154-5035"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55154-5035
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1771d3bf-954d-49ea-b260-3d356e5dcfa5